U.S. markets open in 1 hour 13 minutes

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.1000-0.2000 (-4.65%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/23/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
182.09M69.16M43.15M78.41M44.69M
Enterprise Value 3
125.16M-9.85M-31.87M17.55M-39.91M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
31.9915.3510.178.692.54
Price/Book (mrq)
3.691.190.620.920.33
Enterprise Value/Revenue 3
22.63-4.81-22.6516.03-40.60
Enterprise Value/EBITDA 6
-1.950.912.13-0.991.93

Trading Information

Stock Price History

Beta (5Y Monthly) 1.29
52-Week Change 3115.79%
S&P500 52-Week Change 311.99%
52 Week High 35.0400
52 Week Low 30.7000
50-Day Moving Average 33.1946
200-Day Moving Average 32.1095

Share Statistics

Avg Vol (3 month) 3502.63k
Avg Vol (10 day) 3318.88k
Shares Outstanding 542.84M
Float 29.56M
% Held by Insiders 110.01%
% Held by Institutions 184.81%
Shares Short (Oct 14, 2020) 4645.38k
Short Ratio (Oct 14, 2020) 41.05
Short % of Float (Oct 14, 2020) 41.58%
Short % of Shares Outstanding (Oct 14, 2020) 41.51%
Shares Short (prior month Sep 14, 2020) 4591.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,166.99%

Management Effectiveness

Return on Assets (ttm)-26.70%
Return on Equity (ttm)-74.47%

Income Statement

Revenue (ttm)5.53M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)130.90%
Gross Profit (ttm)-63.61M
EBITDA -66.54M
Net Income Avi to Common (ttm)-69.48M
Diluted EPS (ttm)-2.4280
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.11M
Total Cash Per Share (mrq)1.59
Total Debt (mrq)14.44M
Total Debt/Equity (mrq)29.24
Current Ratio (mrq)4.00
Book Value Per Share (mrq)1.16

Cash Flow Statement

Operating Cash Flow (ttm)-61.38M
Levered Free Cash Flow (ttm)-34.68M